Neurobiology of obesity.
Markus
Annette
A
D000818:Animals; D001069:Appetite Regulation / Q000187:drug effects / Q000502:physiology*; D016739:Behavior, Addictive / Q000503:physiopathology / Q000523:psychology; D006801:Humans; D007031:Hypothalamus / Q000187:drug effects / Q000378:metabolism* / Q000503:physiopathology; D020738:Leptin / Q000378:metabolism; D009316:National Institutes of Health (U.S.) / Q000639:trends; D009434:Neural Pathways / Q000187:drug effects / Q000378:metabolism* / Q000503:physiopathology; D009765:Obesity / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology*; D043884:Receptor, Cannabinoid, CB1 / Q000037:antagonists & inhibitors / Q000378:metabolism; D014481:United States; D000521:alpha-MSH / Q000235:genetics / Q000378:metabolism*
D020738:Leptin; D043884:Receptor, Cannabinoid, CB1; D000521:alpha-MSH